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1. Introduction 
Isoelectric focusing (IEF) in acrylamide gel slabs 
[l] can distinguish between different immunoglo- 
bulin molecules on the basis of differences in their 
isoelectric points. The resolution of the system for 
mouse immunoglobulins is high; thus, Kreth and 
Williamson [2] examined the products of over 300 
clones producing anti-NIP antibody, and found only 
5 pairs of indistinguishable antibodies (‘overlaps’) 
on making all possible comparisons between IEF 
spectra of the clones. Similarly, Pink and Askonas 
[3] found only 5 definite overlaps in about 2400 
comparisons between clones producing antidinitro- 
phenyl-lysine antibodies cross-reactive with the trini- 
trophenyl hapten. Even molecules with very similar 
primary structures and idiotypic specificities, such 
as the phosphoryl-choline binding mouse myeloma 
proteins TEPC-15 and HOPC-8 [4] , can be distin- 
guished by this technique (J. R. L. Pink, unpublished 
results). 
Williamson et al. [5] have given arguments (based 
on parameters uch as the observed average number 
of bands seen after focusing of a monoclonal immuno- 
globulin, the variability in spacing between them, and 
the width of one band; see Results and discussion) 
that the IEF technique can resolve as many as 50 000 
different mouse immunoglobulins. The power of the 
technique, however, is in practice determined by the 
probability that two different immunoglobulins will 
appear to be identical in IEF pattern. This probabil- 
ity would be the reciprocal of the number of resolv- 
able patterns, i.e. l/SO 000, if all antibody patterns 
occurred with equal frequency. Since this is most 
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unlikely to be the case, the ability of IEF to distin- 
guish different immunoglobulins must be evaluated 
empirically. To our knowledge, this has not been done 
for immunoglobulins of any species. 
Here we have investigated the resolution of IEF for 
human immunoglobulins by comparing the banding 
patterns of 45 different human myeloma proteins, and 
determining the parameters which affect the ability 
of the technique to distinguish one myeloma protein 
from another. We estimate that the probability of 
being unable to distinguish between two such proteins 
is of the order of 1: 5000 (that is, of 5000 comparisons 
between structurally different immunoglobulins, one 
comparison would appear to be between identical 
proteins). 
2. Materials and methods 
Human myeloma sera were obtained from various 
clinical institutes and laboratories in Switzerland. 
Myeloma proteins were typed for light chain class and 
heavy chain subclass as described by Skvaril and 
Barandun [6]. In some cases, myeloma proteins were 
purified by Pevikon block electrophoresis followed by 
gel filtration through Sephadex G-200. 
The sample studied consisted of 32 IgGl myeloma 
protein-containing sera (18 K and 15 A),), and 12 
purified IgGl myeloma proteins (8 K and 4 h). One 
serum contained two (IgGl, K) myeloma proteins. 
Isoelectric focusing of 5--30 1.11 serum samples, or 
100 pg protein samples, in acrylamide gel slabs con- 
taining 1% Ampholine was performed according to 
Awdeh et al [ 11. Groups of lo- 15 sera or proteins 
were initially run on pH 3.5510 gels, and then on 
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appropriate narrower pH gradients. Isoelectric 
points of the various bands given by each protein were 
derived from measurements of gel pH made with a 
flat electrode [7]. Gels were stained with bromphenol 
blue after determination of the pH gradient. 
3. Results and discussion 
Fig. 1 shows that myeloma proteins can be identi- 
fied after isoelectric focusing of whole sera, and that 
sera containing biclonal myeloma proteins or raised 
levels of all Ig species can be distinguished from those 
containing monoclonal myeloma proteins. The pro- 
teins studied focused between about pH 6 and pH 9, 
with a majority focusing between pH 7.5 and pH 9, 
as also found by other workers for whole human IgG 
or IgGl subclass [S] . There was no significant 
difference in the distribution of K and X chain types 
over this range. 
The number of bands given by a single myeloma 
protein ranged from 2 to 9, the most common values 
being 4 and 5; the spacing between them varied from 
0.07 to 0.17 pH units. These figures are similar to 
those obtained for mouse immunoglobulins [5] . The 
spacing between bands of a single protein is rather 
Fig.1. Isoelectric focusing patterns of 20 b1 wmples of (a)five myelomn protein-containing hun~an sera; (b)serum containing two 
mycloma proteins; (c)hyper~ammaglobulinetnic and normal sera. Arrows are at pH 8.5 (top) and 7.5 (bottom). 
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Fig.2. Resolution of isoelectric focusing for human myeloma proteins. In (a) and (b) the leading bands of the proteins being 
compared can be distinguished, since they focus at pZs which differ by about 0.01 pH units. In (c) and (d) the leading bands of 
the proteins being compared have indistinguishable pZs and in (e) and (f) the leading two bands of the proteins being compared 
are indistinguishable, but the pZs of minor bands arc different in each case. Arrows are at pH 8.5 (top) and 7.5 (bottom). 
regular, as also observed for mouse immunoglobulins; 
some examples are shown in fig.2. The width of a 
single band is about 0.03 pH units, so that bands can 
be resolved when more than about 0.01 pH units 
apart (fig.2). 
No two proteins gave identical banding patterns. 
In five cases, the leading bands of two proteins 
coincided and in two of these cases, the second bands 
also overlapped; but in each case there were consistent 
differences in the positions of minor bands (fig.2). 
The resolving power of IEF for mouse anti-hapten 
antibodies is known to be very high [2,3,5]. The 
results reported here show that the r solving power 
of the technique for human immunoglobulins is also 
high; the fact that of 45 randomly chosen IgGl 
myeloma proteins (both K and A), all gave distinc- 
tive banding patterns, suggests that the probability 
P of finding identical patterns when comparing such 
proteins is at least 45’/2 (or about IOOO), and thus 
that the technique will resolve at least this number 
of different human IgG proteins. 
Another estimate of P can be made as follows. If 
only the leading bands of each protein are compared, 
the probability of finding identical patterns is about 
1: 200 (since 5 cases were seen in about 1000 com- 
parisons); if the leading two bands of each protein 
are considered, the probability of finding identical 
patterns is still quite high -- about 1 in 500. Considera- 
tion of additional (3rd, 4th, etc.) bands increases the 
probability of resolving structurally different proteins, 
but not by more than one order of magnitude [5] 
since the band spacings of each protein tend to be 
regular (tig.2). Thus we estimate that the actual 
probability of being unable to resolve randomly- 
chosen, structurally-different human immunoglo- 
bulins by IEF under the conditions described here is 
of the order of 1: 5000 - about an order of magnitude 
higher than the ‘best case’ limit (about 1 in 30 000 
for human proteins) derived* as suggested by 
*The ‘best case’ limit or maximum number of immunoglo- 
bulins resolvable by IEF, is taken to be rl X r2 X 10/W’ 
where W is the pZ difference between bands which can just 
be distinguished (0.01 pII units), Y, is the pH range over 
which the proteins focus (3 plI units) and rz is the difference 
between maximum and minimum spacings of the leading and 
2nd bands of the proteins considered (0.1 pH units). The 
factor 10 (a guess, see text) is introduced to allow for further 
resolution on consideration of the proteins’ 3rd, 4th, etc. 
bands. 
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Williamson [S] . The difference is presumably due to 
the fact that the ‘best case’ limit is obtained by 
making some simplifying assumptions: for example, 
that all band spacings between the largest and smal- 
lest observed (here 0.07 and 0.17 pH units) are 
equally probable. Non-randcmness in this distribu- 
tion will increase the estimated P. 
The resolution of IEF will of course depend some- 
what on the experimental conditions employed, and 
more importantly, on the sort of immunoglobulin being 
studied. Thus there is evidence [8] that structurally 
different guinea-pig anti-DNP antibodies, most of 
which have high isoelectric points, relatively often 
give indistinguishable IEF patterns. However, the 
parameters affecting resolution in IEF of human 
myeloma proteins and mouse anti-NIP antibodies [5] 
are rather similar. In fact, since the value of P (1: 5000) 
obtained for human proteins is not significantly differ- 
ent from the proportion of overlaps found in experi- 
ments involving comparisons of antihapten antibodies 
in mice (5 out of 50 000 [2] and 5 to 7 out of 2400 
[3]) the work reported here suggests that the limit of 
resolution of the IEF method may have been reached 
in these experiments; and thus that the numbers of 
structurally different antibodies made by an inbred 
mouse strain to the hapten NIP [2], or the cross- 
reacting haptens di- and trinitrophenyl-lysine [3] 
may well exceed the reported minimum values of 
8000 and 500 respectively. 
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